Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Clindamycin Hydrochloride Patent Expiration

Clindamycin Hydrochloride was first introduced by Pfizer Inc in its drug Cleocin Hydrochloride on Approved Prior to Jan 1, 1982. 14 different companies have introduced drugs containing Clindamycin Hydrochloride.


About Veterinary Clindamycin Hydrochloride

Clindamycin Hydrochloride is used in drugs marketed by 5 different companies: Zoetis Inc, First Priority Inc, Felix Pharmaceuticals Pvt Ltd, Cronus Pharma Specialities India Private Ltd, Virbac Ah Inc.

Other drugs containing Clindamycin Hydrochloride are: Antirobe capsules , Clindamycin hydrochloride capsules , Clindamycin hydrochloride oral drops , Antirobe aquadrops

Clindamycin Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Clindamycin Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Clindamycin Hydrochloride. The first generic version for Clindamycin Hydrochloride was by Pharmacia And Upjohn Co and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Glenmark Pharmaceuticals Ltd and was approved on Mar 10, 2023.

Given below is the list of companies who have filed for Clindamycin Hydrochloride generic, along with the locations of their manufacturing plants worldwide.